These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3111591)

  • 1. Prediction of resources needed to achieve the national target for treatment of renal failure.
    Wood IT; Mallick NP; Wing AJ
    Br Med J (Clin Res Ed); 1987 Jun; 294(6585):1467-70. PubMed ID: 3111591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of resources for renal transplantation in the United Kingdom.
    Sells RA; Macpherson S; Salaman JR
    Lancet; 1985 Jul; 2(8448):195-7. PubMed ID: 2862381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited resources and the treatment of end-stage renal failure in Britain and the United States.
    Rennie D; Rettig RA; Wing AJ
    Q J Med; 1985 Jul; 56(219):321-36. PubMed ID: 3912791
    [No Abstract]   [Full Text] [Related]  

  • 4. Policies regarding treatment of end-stage renal disease in the United States and United Kingdom.
    Marine SK; Simmons RG
    Int J Technol Assess Health Care; 1986; 2(2):253-74. PubMed ID: 10301020
    [No Abstract]   [Full Text] [Related]  

  • 5. A flexible model for planning facilities for patients with end-stage renal failure.
    Wood IT; Mallick NP; Moores B
    Br Med J; 1980 Aug; 281(6240):575-7. PubMed ID: 7000265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purchasing services for end stage renal failure: the potential and limitations of existing information sources.
    Beech R; Mandalia S; Melia J; Mays N; Swan A
    Health Trends; 1993; 25(2):60-4. PubMed ID: 10130809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life and death in a welfare state: end-stage renal disease in the United Kingdom.
    Halper T
    Milbank Mem Fund Q Health Soc; 1985; 63(1):52-93. PubMed ID: 3923389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tale of two cultures; do we differ?
    Hoffenberg R
    Ann N Y Acad Sci; 1988; 530():16-23. PubMed ID: 3044219
    [No Abstract]   [Full Text] [Related]  

  • 10. High cost dialysis and transplantation--dilemmas for nephrologists and nations.
    Wing AJ
    Ulster Med J; 1985 Aug; 54 Suppl(Suppl):S62-9. PubMed ID: 3909584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL).
    Garcia-Garcia G; Monteon-Ramos JF; Garcia-Bejarano H; Gomez-Navarro B; Reyes IH; Lomeli AM; Palomeque M; Cortes-Sanabria L; Breien-Alcaraz H; Ruiz-Morales NM
    Kidney Int Suppl; 2005 Aug; (97):S58-61. PubMed ID: 16014102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation.
    Garg PP; Frick KD; Diener-West M; Powe NR
    N Engl J Med; 1999 Nov; 341(22):1653-60. PubMed ID: 10572154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the future demand for renal replacement therapy in England using simulation modelling.
    Davies R; Roderick P
    Nephrol Dial Transplant; 1997 Dec; 12(12):2512-6. PubMed ID: 9430844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NSF for Renal Services. Part One: Dialysis and transplantation.
    Hainsworth T
    Nurs Times; 2004 Feb 3-9; 100(5):28-9. PubMed ID: 14999827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Need for an incentive-based reimbursement policy toward quality care for dialysis patient management.
    Hidai H
    Kidney Int; 2000 Jul; 58(1):363-73. PubMed ID: 10886583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis utilization in the Toronto region from 1981 to 1992. Toronto Region Dialysis Committee.
    Mendelssohn DC; Chery A
    CMAJ; 1994 Apr; 150(7):1099-105. PubMed ID: 8137190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The commissioning of renal services.
    Greenood R; Farrington K
    Practitioner; 1999 Jul; 243(1600):351. PubMed ID: 10534868
    [No Abstract]   [Full Text] [Related]  

  • 18. The financing and organization of medical care for patients with end-stage renal disease in Sweden.
    Wikström B; Fored M; Eichleay MA; Jacobson SH
    Int J Health Care Finance Econ; 2007 Dec; 7(4):269-81. PubMed ID: 17657602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of resources needed to achieve the national target for treatment of renal failure.
    Michael J; Adu D
    Br Med J (Clin Res Ed); 1987 Oct; 295(6602):850. PubMed ID: 3119064
    [No Abstract]   [Full Text] [Related]  

  • 20. On the impact of and need for chronic dialysis and renal transplantation.
    Kjellstrand CM; Shideman J
    ASAIO Trans; 1988; 34(3):328-33. PubMed ID: 3058178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.